Acknowledgments
All studies were funded by the sponsor, Takeda Pharmaceutical Company Ltd. We thank the participants and investigators involved in the studies. Under the direction of the authors and funded by Takeda Pharmaceutical Company Ltd, Aimee Jones DPhil (ORCID number: 0000-0003-0279-1814) and Erin Aldera PhD (ORCID number: 0000–0001-7935–1337) of Oxford PharmaGenesis, Oxford, UK, provided writing assistance for this publication, in accordance with Good Publication Practice 3 (GPP3) guidelines (